| 发明名称 |
IN VIVO EFFICACY OF NY-ESO-1 PLUS ADJUVANT |
| 摘要 |
The invention relates to the discovery that administration of NY-ESO-1 protein, in combination with a saponin based adjuvant leads to an unexpectedly strong immune response against NY-ESO-1 expressing cells. Preferably, the combination is administered intramuscularly. |
| 申请公布号 |
US2016000894(A1) |
申请公布日期 |
2016.01.07 |
| 申请号 |
US201514698237 |
申请日期 |
2015.04.28 |
| 申请人 |
CSL Limited ;Ludwig Institute for Cancer Research |
发明人 |
Cebon Jonathan;Davis Ian;Chen Weisan;Green Simon |
| 分类号 |
A61K39/00;G01N33/574;A61K9/00 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
Parkville AU |
